USING TAMSULOSINE IN THE MANAGEMENT OF LOWER URETERIC CALCULI: OUR EXPERIENCE OF MEDICAL EXPUSIVE THERAPY OF URETERIC CALCULI IN A RANDOMIZED CONTROLLED TRIAL
DOI:
https://doi.org/10.59058/jaimc.v20i2.34Keywords:
Tamsulosin, stone expulsion, pharmacologic therapy, ureteric calculiAbstract
Background: Lower ureteric calculi can be treated by different modalities. There are many minimally invasive interventional (e.g.,ESWL, ureterorenoscopy, the holmium: YAG laser and basket devices) as well as expectant (watchful waiting) treatments are in practice for the management of distal ureteric calculi. selected method depend on the type of equipment available, location, type and size of stone, needs of the patient and skills of the surgeon. Most of the work on the potency of tamsulosin in lower ureteric calculi expulsion has been done in the developed countries.
Methods: Our randomized controlled trial in Avicenna Hospital Lahore included 100 patients over 18 years of age with stone Size ≤8mm in distal one third of ureter. Patients were randomly assigned into two groups (A & B). Group A Patients were given Capsule Tamsulosin 0.4 mg, once daily up to four weeks while group B patients were given placebo, one Capsule daily up to four weeks. The final result was the expulsion rate.
Informed consent was obtained from all the patients. Stone Expulsion time, analgesia requirement, need for
hospitalization and drug adverse effects were secondary endpoints.
Results: A total of 49 patients in group A and 48 patients in group B came for follow up, therefore 97 out of 100 patients were evaluated. Mean age of the patients was 36.34 years (range 18–57 years). Mean stone size was 5.78 mm (range 4–8 mm) in largest dimension. A stone expulsion rate of 85.71% (42 patients) was noted in group A and 54.20% (26 patients) in group B. Group A showed a statistically significant advantage in terms of stone expulsion rate (p=0.032). Considering expulsion time in days group A demonstrated statistically significant advantage (p=0.015). Regarding age, sex, stone size and stone lateralization (right/left), there was no remarkable difference between the group A and B. No drug adverse effects were seen in both the groups.
Conclusion: Tamsulosine can be used as medical expulsion therapy in lower ureteric calculi of size less than or equal to 8mm.
References
Lingeman JE, Matlaga BR, Evan AP. Surgical manage- ment of upper urinary tract calculi. In: Kavoussi LR, Novick AC, Partin AW, Peters AC, Wein AJ, eds. Campbell- Walsh urology. Saunders Elsevier, Phila- delphia 2007;1431–1507.
Finlayan B, Ackermann D. Overview of surgical treat- ment of urolithiasis with special reference to lithotripsy. J Urol 1989;141:778–9.
Eisenberger F, Fuchs G, Miller K, Bub P, Rassweiler
J. Extra corporeal shock wave lithotripsy (ESWL) and endourology: an ideal combination for the treatnent of kidney stones. World J Urol 1985;3:41–7.
Stoller ML. Urinary stone disease. In: Tanagho EA, McAninch JW. Smith’s general urology. 17th ed. Mc Graw hill, New York 2008;246–77.
De Sio M, Autorino R, Di Lorenzo G, Damiano R, Giordano D, Cosentino L, et al. Medical expulsive treatment of distal ureteral stone using tamsulosin: a single- centerexperience. JEndourol 2006; 20(1): 12–5.
Ferre RM, Wasielewski JN, Strout TD, Perron AD. Tamsulosin for ureteral stone in the emergency depart- ment: a ramdamized control trial. Ann Emerq Med 2009;54(3):432–9.
Stamatelou KK, Francis ME, Jones CA, Nyberg LM,
Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817–23.
Lotan Y, Gettman MT, Roehrborn CG, Cadeddu JA, Pearle MS. Management of ureteral calculi: A cost comparison and decision making analysis. J Urol 2002;167(4):1621–9.
Ueno A, Kawamura T, Ogawa A, Takayasu H. Relation of spontaneous passage of ureteral calculi to size. Urology 1977;10(6):544–6.
Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 1999;162(3):688–90.
Porpiglia F, Fiori C, Ghipnone G, Vaccino D, Billia M, Morra I et al. A second cycle of tamsulosin in patients with distal ureteric stones: a prospective randomized trial. BJU Int 2009;103(12):1700–3
Dellabella M, Milanese G, Muzzonigo G. Efficacy of tamsulosin in the medical management of juxta vesical ureteral stones. J Urol 2003;170:2202–5.
Kupeli B, Irkilata L, Gurocak S, Tunc L, Kirac M, Karaoglan U, et al. Does tamsulosin enhance lower ureteral stone clearness with or without shock wave lithotripsy? Urology 2004;64(4):1111–5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 JAIMC
This work is licensed under a Creative Commons Attribution 4.0 International License.
The articles published in this journal come under creative commons licence Attribution 4.0 International (CC BY 4.0) which allows to copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially under following terms.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The editorial board of the Journal strives hard for the authenticity and accuracy of the material published in the Journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board. Many software like (Google Maps, Google Earth, Biorender (free version)) restricts the free distribution of materials prepared using these softwares. Therefore, authors are strongly advised to check the license/copyright information of the software used to prepare maps/images. In case of publication of copyright material, the correction will be published in one of the subsequent issues of the Journal, and the authors will bear the printing cost.
